Introduction
Diabetes mellitus is one of the most common endocrine metabolic disorders. Studies have shown that hepatobiliary disorders, such as the infl ammation and necrosis or fi brosis of non-alcoholic fatty liver disease can follow diabetes [1, 2] . It has been reported that the standardized mortality rate from end-stage liver disease (i.e., cirrhosis) in diabetic patients is higher than those with cardiovascular disease [3] . Several mechanisms can cause pancreatic β -cell dysfunction, including chronic infl ammation, oxidative stress, excessive hyperglycemia and nutrient levels, lipotoxicity, endoplasmic reticulum (ER) stress (ERS), etc. [4 -6] . A previous study has shown that hepatic fat accumulation and oxidative stress play a critical role in the development of diabetic liver injury The ER is a complex intracellular membranous network that regulates protein synthesis and folding. Alterations in ER homeostasis, due to increased protein synthesis, accumulation of misfolded proteins, alterations in the calcium, or the redox balance of the ER, lead to a condition called " ERS " [15] . To overcome the deleterious eff ects of ERS induction, cells have evolved various protective strategies, which are known as the " unfolded protein response (UPR) " [16] . Furthermore, the results from these reports have suggested that induction of ERS is closely associated with the energy metabolism, especially the lipid metabolism with the involvement of UPR signaling pathways. Rutkowski and Cols examined the contribution of each arm of the UPR pathway to the regulation of metabolic genes and development of hepatic dyslipidemia and concluded that all three arms of UPR signaling pathway: double-stranded RNAdependent protein kinase-like ER kinase (PERK), inositol-requiring enzyme 1 α (IRE1 α ), and activating transcription factor 6 (ATF6) are activated, leading to metabolic dysregulation [17] .
When ERS is prolonged in the presence of hyperglycemia condition, the ER triggers the apoptotic pathway by activating the CCAAT/enhancer-binding protein homologous protein (CHOP) [18] , the IRE1 -tumor necrosis factor (TNF) receptor-associated factor 2 (TRAF2) -apoptosis signal-regulating kinase 1 (ASK1) -mitogen-activated protein kinase (MAPK) pathway [19] , and/or the ER-localized cysteine protease caspase-12 [20] . Moreover, cell death signaling cascades including p38 MAPK and ASK1 are also activated by pro-infl ammatory cytokine TNF α , interleukin 1 β (IL-1 β ), and toll-like receptor 4 (TLR4) and by the activation of the UPR signaling marker IRE1 α in diabetic liver. Diabetes involving both infl ammation and ERS lead to hepatic apoptosis and liver damage.
Curcumin is the active ingredient of the traditional herbal remedy and dietary spice turmeric ( Curcuma longa) and is the subject of clinical trials for various diseases such as cancer, Alzheimer ' s disease, and ulcerative colitis [21] . The polyphenol curcumin (diferuloylmethane) comprises 2 -8% of most turmeric preparations and is generally regarded as its most active component, having potent antioxidant, anti-infl ammatory, and anticarcinogenic properties. Curcumin has been shown to modulate the activity of protein kinases [22] , membrane ATPases [23] , and transcription factors [24, 25] . It is also reported that curcumin plays an important role in diminishing myocardial ERS signaling proteins and in decreasing the key regulator or inducer of apoptosis in experimental autoimmune myocarditis rats [26] . A previous study has pointed to the protective eff ect of curcumin on acute liver injury by inhibiting nuclear factor kappa B (NF-κ B) and oxidative stress [27] . However, to the best of our knowledge, studies have not revealed the eff ect of curcumin on ERS in diabetic liver. Although many aspects of curcumin-induced cytoprotection are studied, the molecular mechanism by which curcumin protects liver tissues against streptozotocin (STZ)-induced liver injury is not clear. The present study was designed to shed light on this issue.
Materials and methods

Materials
Unless otherwise stated, all reagents were of analytical grade and purchased from Sigma (Tokyo, Japan).
Animals and experimental design
All animals were treated in accordance with the guidelines for animal experimentation of our institute [28] . Male Sprague-Dawley rats (weight: 250 -300 g) were obtained from Charles River Japan Inc. (Kanagawa, Japan). Animals were housed in a temperature of 23 Ϯ 2 ° C and humidity of 55 Ϯ 15%, and were submitted to a 12-h light/ dark cycle, and allowed free access to standard laboratory chow and tap water. Animals were allowed to fast for 4 h and then diabetes was induced by a single intraperitoneal ( i.p. ) injection of freshly prepared solution of STZ (SigmaAldrich Inc., Saint Louis, MO, USA) at a dose of 55 mg/ kg, diluted in citrate buff er: 20 mM (pH: 4.5) . Forty-eight hours later, blood glucose was measured by tail vein sampling using Medisafe chips (Terumo Inc., Tokyo, Japan). Diabetes was defi ned as a morning blood glucose reading of Ն 300 mg/dL. Thirty rats were randomly divided into three groups (n ϭ 10/group): non-diabetic normal control group (Normal); diabetic rats treated with vehicle, 1% gum Arabic (Control); and diabetic rats treated with curcumin 100 mg/kg/day [29] diluted in vehicle, 1% gum Arabic (Curcumin) (curcumin was purchased from Sigma-Aldrich, Tokyo, Japan). Curcumin treatment was started at 3 weeks after STZ injection and was administered via oral gavage for 8 weeks. All rats were sacrifi ced at 11 weeks after the induction of diabetes for analysis of liver tissues.
Biochemical analysis
Each week, rats were weighed and their blood glucose levels were measured. Urine samples were collected over a 24-h period in individual metabolic cages for the measurement of protein in urine at 1, 3, 7, and 11 weeks and were determined by the Bradford method. At the end of experimentation, heparinized whole blood was collected from anesthetized rats via heart puncture. Ethylenediaminetetraacetic acid -blood was centrifuged at 3000 g, for 15 min at 4 ° C for the separation of plasma. The plasma was used for the estimation of triglyceride (TG), total cholesterol (TC), and alanine aminotransferase (ALT).
Histopathological analysis
Formalin-fi xed liver sections (4 μ m) were stained with hematoxylin and eosin (H & E) or periodic acid Schiff (PAS). Morphological analysis was done by computerized image analysis system on ten microscopic fi elds per section examined in a 400-fold magnifi cation (CIA-102; Olympus), with the observer blind to the study group [30, 31] .
Western blotting analysis
The liver tissue protein lysate was prepared using a method similar to that described by Soetikno [32] . The total protein concentration in the samples was measured by the bicinchoninic acid method. For the determination of protein levels, equal amounts of protein extracts (50 μ g) were separated by 7.5 -15% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (Bio-Rad, CA, USA) and transferred electrophoretically to nitrocellulose membranes. Membranes were blocked with 5% non-fat dry milk or bovine serum albumin (BSA) in Tris-buff ered saline Tween (20 mM of Tris, pH: 7.6 , 137 mM of NaCl, and 0.1% Tween 20). Primary antibodies against glucose-regulated protein 78 (GRP78), IRE1 α , p-IRE1 α , TRAF2, ATF6, PERK, p-PERK, CHOP/ growth arrest and DNA-damage-inducible protein (GADD153), TNF α , IL-1 β , TLR4, and β -tubulin were obtained from Santa Cruz Biotechnology, Santa Cruz, CA, USA. Primary antibodies against bcl2 (B-cell lymphoma 2), cleaved caspase-3, phospho (p)-p38MAPK, and ASK1 were obtained from Cell Signaling Technology Inc., Beverly, MA, USA. The primary antibody, cleaved caspase-12 was obtained from Bio Vision Inc., Milpitas, CA, USA. All the antibodies were used at a dilution of 1:1000. The membrane was incubated overnight at 4 ° C with the primary antibody, and the bound antibody was visualized using the respective horseradish peroxidase (HRP)-conjugated secondary antibodies (Santa Cruz Biotechnology Inc.) and chemiluminescence developing agents (Amersham Biosciences, Buckinghamshire, UK). The levels of β -tubulin, PERK (for p-PERK), and IRE1 α (for p-IRE1 α ) were estimated in every sample to check for equal loading of samples. Films were scanned, and band densities were quantifi ed by densitometric analysis using the Scion Image program (Epson GT-X700, Tokyo, Japan).
Immunohistochemistry
Formalin-fi xed, paraffi n-embedded liver tissue sections were used for immunohistochemical staining. After deparaffi nization and hydration, the slides were washed in Tris-buff ered saline (TBS; 10 mM/L of Tris HCl, 0.85% NaCl, pH: 7.2). Endogenous peroxidase activity was quenched by incubating the slides in methanol and 0.3% H 2 O 2 in methanol. After overnight incubation with the primary antibody, that is, mouse monoclonal anti-ED1 antibody (diluted 1:50) (sc-59103; Santa Cruz Biotechnology Inc. CA, USA) at 4 ° C, the slides were washed in TBS, and then HRP-conjugated goat anti-mouse secondary antibody was added and the slides were further incubated at room temperature for 1 h. The slides were washed in TBS and incubated with diaminobenzidine tetrahydrochloride as the substrate, and counterstained with hematoxylin. A negative control without primary antibody was included in the experiment to verify the antibody specifi city. ED1-positive hepatocytes were counted in 100 hepatocytes/ group under 200-fold magnifi cation and expressed as cells/hepatocyte cross section (gcs) [33] .
Statistical analysis
All values are expressed as means Ϯ standard error of mean (SEM) and were analyzed using one-way analysis of variance (ANOVA) followed by Tukey ' s methods for post-hoc analysis or two-tailed t-test when appropriate. A value of p Ͻ 0.05 was considered statistically significant. For statistical analysis, GraphPad Prism 5 software (San Diego, CA, USA) was used.
Results
Biochemical parameters in experimental animals
For the confi rmation of diabetic model and the eff ect of treatment, the blood glucose level was checked periodically, which is shown in Figure 1 ; before treatment, the blood glucose level was signifi cantly higher in diabetic rats than that of normal group but during the treatment period of 6 weeks curcumin treatment signifi cantly decreased this blood glucose level. Moreover, it is also reported that curcumin has the capability to improve the pancreatic islets [34] and has been demonstrated in prevention of isolated β -cells death and dysfunction induced by STZ [34, 35] .
As shown in Table I , body weight was signifi cantly decreased in diabetic rats, but curcumin treatment could not prevent this declined body weight. The ratio of liver weight and body weight (g/kg) was signifi cantly increased in untreated diabetic rats compared with that in normal ratscurcumin treatment reduced this ratio. Compared with the normal group, diabetic rats developed elevated mean plasma
ERS is one of the strategies involved in the reduction of liver complications of diabetes. In the present study, curcumin-treated animals had shown signifi cant attenuation of GRP78, and cleaved caspase-12 was slightly attenuated when compared with the control group (Figure 2A and B).
Eff ect of curcumin on expression of UPR signaling proteins in liver
The signals from activated UPR molecules to the relevant eff ector proteins are conveyed by three diff erent proteins: PERK, IRE1 α , and ATF6 α . As expected, here we have found that the phosphorylation of PERK protein was signifi cantly increased in the diabetic rats compared with that in the normal Sprague-Dawley (SD) rats ( Figure 3A) . Diabetic rats have displayed a signifi cant upregulation in the hepatocyte expression levels of p-IRE1 α protein compared with the normal SD rats ( Figure 3B ). Curcumin treatment signifi cantly attenuated the increased liver p-PERK and p-IRE1 α levels. But interestingly, we did not fi nd any signifi cant diff erence in the level of ATF6 α protein expression in the diabetic rats compared with that in the normal SD rats ( Figure 3C ). 
Eff ect of curcumin on ERS marker protein
Activation of GRP78 protein expression was used to demonstrate the ERS induction, whose expression is reported to be increased in the diabetic rats. ERS leads to the activation of caspase-12 and other markers involved in the hepatic changes associated with diabetes mellitus. Our study with diabetic rats also revealed the involvement of ERS as evidenced by a signifi cant increase in the hepatic GRP78 expression but cleaved caspase-12 expression was not so signifi cant. Prevention of
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Eff ect of curcumin on hepatocyte protein expression levels of CHOP/GADD153 in the diabetic rats
It has been proposed that enhancement of the hepatocyte protein expression of CHOP/GADD153 gene could eventually induce apoptosis. Immunoblot analysis revealed that the diabetic rats have demonstrated signifi cant elevation of CHOP/GADD153 protein expression compared with the normal rats ( Figure 4A ) and curcumin treatment significantly decreased the increased liver CHOP expression. 
Eff ect of curcumin on liver expression of TRAF2, ASK1, and p-p38MAPK
The TRAF2 protein expression was signifi cantly higher in the diabetic rats than the normal rats, which was significantly attenuated by curcumin treatment ( Figure 4B ). There was a signifi cant increase in the expression of p-p38MAPK and ASK1 in the diabetic control rats. This result suggests that activation of IRE1 α recruits TRAF2, and then ASK1 directly binds to TRAF2 and gets 284 R. Afrin et al. activated. Curcumin treatment modifi ed these changes in the liver of diabetic rats. Protein expressions of these markers were attenuated signifi cantly in the curcumintreated rats ( Figure 4B -D) .
Eff ect of curcumin on hepatocyte protein expression levels of cleaved caspase-3 and bcl2 in diabetic rats
Immunoblot analysis revealed that the diabetic rats have displayed an increase in the hepatocyte protein expression of cleaved caspase-3 compared with the normal rats ( Figure 5A) and decreased protein expression level of bcl2. This increase in liver of cleaved caspase-3 protein expression was markedly suppressed and signifi cantly increased the bcl2 protein expression by curcumin treatment in the liver of diabetic rats. This clearly indicates that curcumin attenuated the hepatocytes ' apoptosis.
Eff ect of curcumin on infl ammatory marker proteins in the diabetic liver
Infl ammation is involved in the mechanism of metabolism related diseases such as diabetes mellitus and obesity [36, 37] . Infl ammatory cytokines produced by liver infi ltrated autoreactive immune cells are the major factors causing cell death in type 1 diabetes [38] . It has been proposed that ERS pathways play crucial roles in the infl ammatory response. Therefore, we performed Western blot analysis for measuring the hepatocyte protein expression levels of TNF α , IL-1 β , and TLR4 in diabetic rats. The diabetic rats displayed signifi cantly upregulated protein expression levels of TNF α , IL-1 β , and TLR4 compared with the normal rats ( p Ͻ 0.05 and p Ͻ 0.001), and these increases were signifi cantly attenuated by curcumin treatment (Figure 6A -C) .
Histopathological fi ndings
Normal histology was seen in the normal control rats (Figure 7) . The normal liver contains a large amount of glycogen. This, therefore, leads to the intense pink staining of hepatocytes with a PAS stain. In the PAS staining, examined liver sections of normal control rats showed the normal pattern distribution of glycogen granules and a liver section of diabetic rats showed marked depletion in the glycogen granules; meanwhile this glycogen level became increased in curcumin-treated animals ( Figure 7A) . and infl ammation in the portal area were signifi cantly apparent compared with the normal rats and curcumintreated diabetic rats ( Figure 7B ).
Eff ect of curcumin on macrophage (Kupff er cells) infi ltration and fi bronectin accumulation
Macrophages are a heterogeneous population of myeloidderived mononuclear cells that are a critical component of innate immune response [39, 40] . We investigated that livers from normal rats did not show any signifi cant macrophage infi ltration ( Figure 7C ). On the other hand, diabetic rats demonstrated prominent macrophage (ED1-positive cells) recruitment in the liver ( Figure 7C and C1), whereas diabetic rats treated with curcumin showed marked reduction in macrophage activation ( p Ͻ 0.01) ( Figure 7C and C1). Fibronectin accumulation in diabetic rat liver was also signifi cantly higher compared with that of normal control group ( Figure 7D ). When curcumin was given to STZ diabetic groups, the sections of liver showed reduced fi bronectin accumulation ( Figure 7D ).
Discussion
The ER is a membranous network that provides a specialized environment for processing and folding newly synthesized proteins. The ER regulates protein folding, calcium storage, and the biosynthesis of macromolecules such as steroids, lipids, and carbohydrates. Disruption of ER homeostasis, often termed ERS, has been observed in liver and adipose tissue of humans with non-alcoholic fatty liver disease and/or obesity [1,41 -44] . When the metabolic demands increase, which can perturb the protein folding in the ER, the workload of this protein factory is collectively called " ERS " [45] . Song and Scheuner indicated that nutrient fl uctuations and insulin resistance increase pro-insulin synthesis in β -cells beyond the capacity of folding of nascent polypeptide within the ER lumen, thereby disrupting ER homeostasis and triggering the UPR and chronic ERS-promoted apoptosis [14] . Since hepatocytes have a well-developed ER structure, ERS is involved in liver-related disease [46] . As curcumin also has the ERS inhibitory eff ect [26] , in light of the important role of the liver in glucose homeostasis and the pathogenesis of diabetes, we sought to examine the potential eff ect of curcumin on the ERS response signal in hepatocytes of diabetic animals. So, we question the benefi cial function of curcumin on suppressing the ERS in the liver.
The ER lumen provides a specialized environment for protein folding and maturation, and a unique complement of molecular chaperones and folding enzymes [47] . Recent studies have suggested that ERS and UPR signaling are tightly associated with hepatic lipid metabolism [48, 49] . In mammalian cells, UPR activation involves three ERlocalized proteins: IRE1 α , PERK, and ATF6 α [50]. It is currently thought that in unstressed cells, all three proteins are maintained in an inactive state via their association with the ER protein chaperone, GRP78. GRP78 acts as a master regulator of the activation of UPR signaling pathways. Upon ERS, GRP78 is released and sequestered on unfolded proteins, allowing activation of PERK, IRE1 α , and ATF6 α [51]. In the present study, we investigated ERS signaling in diabetic liver and observed the elevated protein expression of GRP78, p-PERK, and IRE1 α in the liver of diabetic rats, which were attenuated by curcumin treatment (Figure 2A, 3A, and B) . However, the expression of ATF6 α was not signifi cant in the liver of diabetic rats compared with that in the liver of normal rats ( Figure 3C) .
Considering all these fi ndings, the increase in GRP78 expression and activation of the UPR are often used as indicators of ERS due to the complexity of directly measuring the ER integrity or protein aggregate levels, we hypothesize that the increase in the protein expression of GRP78 and UPR signaling proteins might actually indicate the induction of ERS in the diabetic rats. Curcumin treatment attenuated the ERS in the liver of diabetic rats by reducing these marker proteins.
Prolonged or insuffi cient ERS may turn physiological mechanisms into pathological consequences. When ERinducing stresses are too severe or prolonged to allow for recovery of ER function, the apoptosis pathway is activated to remove damaged cells [52 -56] . It is proposed that at least three pathways are involved in the ERS-mediated apoptosis [52 -57] . The fi rst is transcriptional activation of the gene for CHOP. The second is activation of the IRE1 -TRAF2 -ASK1 -MAPK pathway. The third is activation of ER-associated caspase- 12. CHOP is expressed at low levels under physiological conditions, but it is strongly induced at the transcriptional level in response to ER stress [14, 52, 53, 58, 59] . The transcription of the CHOP gene is activated by all three ER stress sensors (IRE1 α , ATF6, and PERK) signaling pathways. The activation of PERK plays a dominant role in the induction of transcription factor: CHOP/GADD153 [60] over that of ATF6 α and IRE1 α signaling pathways, although the presence of all three signaling pathways is required to achieve the maximal induction of CHOP [53, 59] . Moreover, the failure of the UPR to ameliorate ERS can lead to cell death via several mechanisms, and CHOP is among the best characterized of the UPR-regulated pro-apoptotic proteins [53] .
Correlating with these results, the phosphorylation of hepatic PERK and CHOP gene expression was shown to be signifi cantly increased in the diabetic rats when compared with that in normal rats. Treatment with curcumin significantly attenuated the changes in the hepatic expression of p-PERK and CHOP/GADD153 and provided evidence for the prevention of ERS, one of the possible mechanisms of hepatic apoptosis in diabetic rats ( Figures 3A and 4A) .
Meanwhile, IRE1 α also appears to mediate rapid degradation of specifi c mRNAs, presumably in an eff ort to reduce production of proteins that require folding in the ER lumen [61, 62] . Under ERS conditions, activated IRE1 α , one of the ERS sensors, recruits TRAF2; then ASK1 directly binds to TRAF2 and is activated. It is thought that the mitochondria pathway is involved in ASK1-mediated apoptosis. In this study, the liver of diabetic rats displayed a signifi cant increase in TRAF2 and ASK1 protein expression ( Figure 4B and C) . Treatment with curcumin signifi cantly downregulated the protein expression of TRAF2 and ASK1 in the liver of diabetic rats. IRE1 α activation has also been linked to the activation of p38MAPK and c-jun N-terminal kinase (JNK) [63 -65] . The p38MAPK and JNK belong to the subfamily of the MAPK superfamily and are classifi ed as a stress response. In the present study, the hepatic levels of phosphorylated forms of p38MAPK are signifi cantly lesser in the curcumin-treated rats when compared with those in the control group ( Figure 4D ), suggesting that curcumin treatment avoided the activation of MAPK signaling cascade with the prevention of stress in the liver of diabetic rats through which it has prevented the liver injury in STZ-induced diabetic rats. Interestingly, in this experiment we did not observe any signifi cant diff erence in the phosphorylation of JNK among the three groups (data are not shown here).
Pro-caspase-12 is localized to the cytosolic side of ER membrane and is activated by ERS but the mechanism has not been confi rmed. It is reported that caspase-12 knockout cells are partially resistant to ERS-induced apoptosis [54] . Interestingly, in this study, we did not observe any signifi cant diff erence in the expression of cleaved caspase-12 among the normal, control, and treatment groups ( Figure 2B ). For further confi rmation of apoptosis in the liver of diabetic rats and the eff ect of curcumin treatment on diabetic liver, we checked the apoptotic marker protein cleaved caspase-3 and anti-apoptotic protein bcl2. In this study, we found that the expression levels of activated caspase-3 were signifi cantly increased and those of the anti-apoptotic proteins bcl2 were reduced in the diabetic liver. Curcumin treatment prevented all of these alterations ( Figure 5A and B) .
Furthermore, it is reported that the ERS pathway plays crucial roles in the infl ammatory response [64, 66, 67] . IRE1 α -TRAF2 complex also involved in the transcriptional induction of infl ammation-related genes. Nanji et al. (2003) have demonstrated the protective eff ect of curcumin in rat liver injury induced by alcohol, where curcumin administration prevented increase in ALT level; and blocked the activation of NF-κ B and the expression of proinfl ammatory cytokines (TNF-α ) and inducible nitric oxide synthase [68] . In this experiment, we found that activation of TLR4 as well as proinfl ammatory cytokine expression levels of TNF α and IL-1 β was increased in diabetic rats compared with that of the levels in normal rats. Curcumin prevented all of these alterations ( Figure 6A -C) . We showed that the signifi cant elevation of ALT in diabetic rats was reduced slightly by curcumin treatment.
Stimuli that injure the liver can activate multiple intracellular stress responses, such as the infl ammatory response. Macrophage or Kupff er cells have been implicated in the pathogenesis of various liver diseases [69] . In the present study, using the accumulation of ED1 as a marker of macrophage activation, we have demonstrated increased activation of macrophage/Kupff er cells in the hepatic tissue of diabetic animals ( Figure 7C and C1) and increased fi bronectin accumulation in diabetic liver ( Figure 7D) . In this study, we demonstrated that macrophage recruitment in diabetic liver is ameliorated by the administration of curcumin. Curcumin is a representative polyphenolic compound found in the dietary spice turmeric. From the morphological study, we found that longterm curcumin treatment improved many pathological changes, degenerated hepatocytes with polymorphic nuclei, and dilated sinusoids and mononuclear cell infi ltrate extending through hepatic tissue in diabetic rats. In the present study, curcumin signifi cantly reduced the blood glucose level. It is also reported that it has the capability to improve the activity of pancreas, thus curcumin is able to increase the insulin secretion [34] . Pancreatic islet cell death is the cause of defi cient insulin production in diabetes. Approaches toward prevention of cell death are of prophylactic importance in control and management of hyperglycemia. Meghana et al. investigated and reported that islet viability and insulin secretion in curcuminpretreated islets are signifi cantly higher than those in islets exposed to STZ alone [35] . Recently, it is reported that curcumin enhances pancreatic β -cell function by inhibiting phosphodiesterase activity and regulated insulin secretion under glucose-stimulated condition [70] . From this experiment, we can conclude that curcumin may indirectly reduce the ERS by reducing hyperglycemia or it may directly reduce the ERS in diabetic liver and protect the liver from damage.
Conclusion
The ERS-related infl ammation and apoptosis are involved in the pathogenesis of various diseases, including hepatopathy. Therefore, the ERS pathway can be a new target for the treatment of those diseases. The result presented here shows that the administration of curcumin inhibits ERS, and ERS-related apoptosis and infl ammation in the liver of STZ-induced diabetic rats. All the above results suggest that the benefi cial eff ect of curcumin occurs, at least in part, through modulation of the UPR signaling pathway. Given these promising preclinical fi ndings, we believe that curcumin might be considered as a potential adjuvant entity for preventing diabetic liver damage.
